相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo
Norliana Khairuddin et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection
Y. Zhang et al.
GENE THERAPY (2011)
Therapeutic Advances in MicroRNA Targeting
Rusty L. Montgomery et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
RNAi momentum fizzles as pharma shifts priorities
Charles Schmidt
NATURE BIOTECHNOLOGY (2011)
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Nathalie M. Goemans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
Erich Koller et al.
NUCLEIC ACIDS RESEARCH (2011)
Potent and systematic RNAi mediated silencing with single oligonucleotide compounds
Jennifer Lapierre et al.
RNA (2011)
Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
Aurelie Goyenvalle et al.
SKELETAL MUSCLE (2011)
Delivery of siRNA Therapeutics: Barriers and Carriers
Jie Wang et al.
AAPS JOURNAL (2010)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
Hong M. Moulton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Clinical status of duplex RNA
Jonathan K. Watts et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in Breast and Pancreatic Cancer Cell Lines
Immanual Joseph et al.
CANCER RESEARCH (2010)
Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers
Natee Jearawiriyapaisarn et al.
CARDIOVASCULAR RESEARCH (2010)
Targeting the Cytoprotective Chaperone, Clusterin, for Treatment of Advanced Cancer
Amina Zoubeidi et al.
CLINICAL CANCER RESEARCH (2010)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2010)
Functional Rescue of Dystrophin-deficient mdx Mice by a Chimeric Peptide-PMO
HaiFang Yin et al.
MOLECULAR THERAPY (2010)
Targeted Delivery of siRNA to Macrophages for Anti-inflammatory Treatment
Sang-Soo Kim et al.
MOLECULAR THERAPY (2010)
Rational Design of Immunostimulatory siRNAs
Michael P. Gantier et al.
MOLECULAR THERAPY (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Safety signal dampens reception for mipomersen antisense
Jim Kling
NATURE BIOTECHNOLOGY (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Targeting microRNAs in cancer: rationale, strategies and challenges
Ramiro Garzon et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe
Annette Lasham et al.
NUCLEIC ACIDS RESEARCH (2010)
Sequence-non-specific effects of RNA interference triggers and microRNA regulators
Marta Olejniczak et al.
NUCLEIC ACIDS RESEARCH (2010)
Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
C. A. Stein et al.
NUCLEIC ACIDS RESEARCH (2010)
Anti-tumor activity of splice-switching oligonucleotides
John A. Bauman et al.
NUCLEIC ACIDS RESEARCH (2010)
Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing
Glen F. Deleavey et al.
NUCLEIC ACIDS RESEARCH (2010)
Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
Ellen Marie Straarup et al.
NUCLEIC ACIDS RESEARCH (2010)
Remembering Paul C. Zamecnik, MD, Father of Antisense (1912-2009) OBITUARY
[Anonymous]
OLIGONUCLEOTIDES (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
Lipid-based systemic delivery of siRNA
Yu-Cheng Tseng et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy
Rene Alvarez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice
HaiFang Yin et al.
HUMAN MOLECULAR GENETICS (2009)
Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cells
Jing Wan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Adam D. Judge et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Less is more: therapeutic exon skipping for Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
LANCET NEUROLOGY (2009)
Asymmetric Shorter-duplex siRNA Structures Trigger Efficient Gene Silencing With Reduced Nonspecific Effects
Chan Il Chang et al.
MOLECULAR THERAPY (2009)
On the road to reading the RNA-interference code
Haruhiko Siomi et al.
NATURE (2009)
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
Marcin Kortylewski et al.
NATURE BIOTECHNOLOGY (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein
Akiko Eguchi et al.
NATURE BIOTECHNOLOGY (2009)
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs (vol 6, pg 549, 2009)
Aly A. Khan et al.
NATURE BIOTECHNOLOGY (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Potent inhibition of microRNA in vivo without degradation
Scott Davis et al.
NUCLEIC ACIDS RESEARCH (2009)
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity
Jesper B. Bramsen et al.
NUCLEIC ACIDS RESEARCH (2009)
miR2Disease: a manually curated database for microRNA deregulation in human disease
Qinghua Jiang et al.
NUCLEIC ACIDS RESEARCH (2009)
Therapeutic Potential of Splice-Switching Oligonucleotides
John Bauman et al.
OLIGONUCLEOTIDES (2009)
siRNA and Innate Immunity
Marjorie Robbins et al.
OLIGONUCLEOTIDES (2009)
Therapeutic Applications of DNA and RNA Aptamers
Kristina W. Thiel et al.
OLIGONUCLEOTIDES (2009)
A Primer for Morpholino Use in Zebrafish
Brent R. Bill et al.
ZEBRAFISH (2009)
2′F-arabinonucleic acids (2′F-ANA) -: History, properties, and new frontiers
Jonathan K. Watts et al.
CANADIAN JOURNAL OF CHEMISTRY (2008)
Chemically modified siRNA: tools and applications
Jonathan K. Watts et al.
DRUG DISCOVERY TODAY (2008)
The business of RNAi therapeutics
Dirk Haussecker
HUMAN GENE THERAPY (2008)
Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
Marjorie Robbins et al.
HUMAN GENE THERAPY (2008)
Overcoming the innate immune response to small interfering RNA
Adam Judge et al.
HUMAN GENE THERAPY (2008)
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function
HaiFang Yin et al.
HUMAN MOLECULAR GENETICS (2008)
miR-122, a paradigm for the role of microRNAs in the liver
Muriel Girard et al.
JOURNAL OF HEPATOLOGY (2008)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
Natee Jearawiriyapaisarn et al.
MOLECULAR THERAPY (2008)
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Mark E. Kleinman et al.
NATURE (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
Asymmetric RNA duplexes mediate RNA interference in mammalian cells
Xiangao Sun et al.
NATURE BIOTECHNOLOGY (2008)
Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
Yasushi Sato et al.
NATURE BIOTECHNOLOGY (2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
Hendrik Poeck et al.
NATURE MEDICINE (2008)
Inhibition of microRNA with antisense oligonucleotides
Christine C. Esau
METHODS (2008)
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Rudy Juliano et al.
NUCLEIC ACIDS RESEARCH (2008)
Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection
Masayuki Sano et al.
NUCLEIC ACIDS RESEARCH (2008)
Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect
Kumiko Ui-Tei et al.
NUCLEIC ACIDS RESEARCH (2008)
Chemical modification patterns compatible with high potency Dicer-substrate small interfering RNAs
Michael A. Collingwood et al.
OLIGONUCLEOTIDES (2008)
An Analysis of Human MicroRNA and Disease Associations
Ming Lu et al.
PLOS ONE (2008)
Effects of local mRNA structure on posttranscriptional gene silencing
Stephen I. Rudnick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
Bo Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
miR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates
Martin M. Fabani et al.
RNA (2008)
Strand-specific 5′-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity
Po Yu Chen et al.
RNA (2008)
MicroRNAs in disease and potential therapeutic applications
Harris S. Soifer et al.
MOLECULAR THERAPY (2007)
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
Dirk Grimm et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Nonviral delivery of synthetic siRNAs in vivo
Saghir Akhtar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Chemical modification: the key to clinical application of RNA interference?
David R. Corey
JOURNAL OF CLINICAL INVESTIGATION (2007)
Synthetic agonists of Toll-like receptors 7, 8 and 9
S. Agrawal et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications
Annemieke Aartsma-Rus et al.
RNA (2007)
Improved silencing properties using small internally segmented interfering RNAs
Jesper B. Bramsen et al.
NUCLEIC ACIDS RESEARCH (2007)
Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development (Publication with Expression of Concern. See vol. 20, 2022)
Wigard P. Kloosterman et al.
PLOS BIOLOGY (2007)
Five- and six-membered conformationally locked 2′,4′′-carbocyclic ribo-thymidines:: Synthesis, structure, and biochemical studies
Puneet Srivastava et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate
Adams Amantana et al.
BIOCONJUGATE CHEMISTRY (2007)
Antisense - down, but not out
Carol Potera
NATURE BIOTECHNOLOGY (2007)
Morpholino, siRNA, and S-DNA compared: Impact of structure and mechanism of action on off-target effects and sequence specificity
James E. Summerton
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Lipid-based nanoparticles for nucleic acid delivery
Weijun Li et al.
PHARMACEUTICAL RESEARCH (2007)
Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting
Daniel De Paula et al.
RNA (2007)
siRNA and isRNA: Two edges of one sword
Martin Schlee et al.
MOLECULAR THERAPY (2006)
Competition for RISC binding predicts in vitro potency of siRNA
Erich Koller et al.
NUCLEIC ACIDS RESEARCH (2006)
Aptamers come of age - at last
David H. J. Bunka et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Widespread siRNA off-target'' transcript silencing mediated by seed region sequence complementarity
Aimee L. Jackson et al.
RNA (2006)
Position-specific chemical modification of siRNAs reduces off-target'' transcript silencing
Aimee L. Jackson et al.
RNA (2006)
Off-target effects by siRNA can induce toxic phenotype
Yuriy Fedorov et al.
RNA (2006)
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Dirk Grimm et al.
NATURE (2006)
LNA-modified oligonucleotides mediate specific inhibition of microRNA function
Ulf Andersson Orom et al.
GENE (2006)
Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo
AD Judge et al.
MOLECULAR THERAPY (2006)
Synthesis and properties of 2′-O,4-C-methyleneoxymethylene bridged nucleic acid
Y Hari et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
C Esau et al.
CELL METABOLISM (2006)
Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302)
Tanya A. Watanabe et al.
OLIGONUCLEOTIDES (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Activation of the mammalian immune system by siRNAs
JT Marques et al.
NATURE BIOTECHNOLOGY (2005)
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
DV Morrissey et al.
NATURE BIOTECHNOLOGY (2005)
Design of a genome-wide siRNA library using an artificial neural network
D Huesken et al.
NATURE BIOTECHNOLOGY (2005)
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
EW Song et al.
NATURE BIOTECHNOLOGY (2005)
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication
DV Morrissey et al.
HEPATOLOGY (2005)
An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis
RM Crooke et al.
JOURNAL OF LIPID RESEARCH (2005)
Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA
CR Allerson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Overexpression of Exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs
R Yi et al.
RNA (2005)
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
DH Kim et al.
NATURE BIOTECHNOLOGY (2005)
Identification of antisense nucleic acid hybridization sites in mRNA molecules with self-quenching fluorescent reporter molecules
LK Gifford et al.
NUCLEIC ACIDS RESEARCH (2005)
Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs
HJ Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Biodistribution of phosphodiester and phosphorothioate siRNA
DA Braasch et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing
G Meister et al.
RNA (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
siRNA Selection Server: an automated siRNA oligonucleotide prediction server
BB Yuan et al.
NUCLEIC ACIDS RESEARCH (2004)
Development of bridged nucleic acid analogues for antigene technology
S Obika
CHEMICAL & PHARMACEUTICAL BULLETIN (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides
RKK Far et al.
NUCLEIC ACIDS RESEARCH (2003)
Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA
A Grünweller et al.
NUCLEIC ACIDS RESEARCH (2003)
Expression profiling reveals off-target gene regulation by RNAi
AL Jackson et al.
NATURE BIOTECHNOLOGY (2003)
Repair of a splicing defect in erythroid cells from patients with β-thalassemia/HbE disorder
T Suwanmanee et al.
MOLECULAR THERAPY (2002)
Restoration of human β-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides
T Suwanmanee et al.
MOLECULAR PHARMACOLOGY (2002)
Developments in RNA chemistry, a personal view
F Eckstein
BIOCHIMIE (2002)
Antisense properties of tricyclo-DNA
D Renneberg et al.
NUCLEIC ACIDS RESEARCH (2002)
DNA analogues: From supramolecular principles to biological properties
CJ Leumann
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
2′-O,4′-C-ethylene-bridged nucleic acids (ENA):: Highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug
K Morita et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
RNA interference is mediated by 21-and 22-nucleotide RNAs
SM Elbashir et al.
GENES & DEVELOPMENT (2001)
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA
DA Braasch et al.
CHEMISTRY & BIOLOGY (2001)
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
C Wahlestedt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
